UNISOL 100 MG/ML SOLUTION FOR INJECTION FOR CATTLE AND PIGS
Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
07-01-2017
Некоторые документы для этого продукта в настоящее время недоступны, вы можете отправить запрос в нашу службу поддержки, и мы сообщим вам, как только мы сможем их получить.
Послать запрос.
Послать запрос.
Активный ингредиент:
ENROFLOXACIN
Доступна с:
Vetpharma Animal Health, S.L.
код АТС:
QJ01MA90
ИНН (Международная Имя):
ENROFLOXACIN
дозировка:
100 Mg/Ml
Фармацевтическая форма:
Solution for Injection
Тип рецепта:
POM
Терапевтическая группа:
Bovine, Porcine
Терапевтические области:
Enrofloxacin
Терапевтические показания :
Antibacterial
Статус Авторизация:
Authorised
Дата Авторизация:
2011-05-06
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Unisol 100 mg/ml solution for injection for cattle and pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE
Enrofloxacin
100.0 mg
EXCIPIENTS
Benzyl alcohol (E1519)
7.8 mg
Disodium edetate
10.0 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear slightly yellowish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and pigs
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 23/12/2016_
_CRN 7025217_
_page number: 1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CATTLE
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida,_
_Mannheimia haemolytica _and _Mycoplasma _spp.
Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of _Escherichia coli_.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of _Mycoplasma bovis _in
cattle less than 2 years old.
PIGS
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida_,
_Mycoplasma _spp. and _Actinobacillus pleuropneumoniae_.
Treatment of infections of the urinary tract caused by enrofloxacin susceptible strains of _Escherichia coli._
Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by enrofloxacin susceptible strains of
_Escherichia coli _and _Klebsiella _spp.
Treatment of infections of t
Прочитать полный документ
